In regards to HSV2 vaccine and 11b trial results (after getting a partner)...come back in 2 years folks.
(Same with oncology).
It's all about Adapt (and Infusion) now.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-46
-
- There are more pages in this discussion • 305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.39 |
Change
-0.160(0.86%) |
Mkt cap ! $363.6M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.33 | $153.5K | 8.273K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8 | $18.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 50 | 1 |
View Market Depth
| Last trade - 15.21pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |